Protagonist Therapeutics Quarterly Balance Sheet
NASDAQ: PTGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Protagonist Therapeutics financial position
As of Jun 30, 2026, Protagonist Therapeutics reported total assets of $885.5 million, up 23.3% from a year earlier against total liabilities of $44.0 million. Shareholders' equity stood at $841.5 million, or 95.0% of assets. The company held $420.1 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 21.71, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Protagonist Therapeutics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 420.08M | 193.71M | 128.39M | 113.71M | 168.54M | 139.65M | 97.25M | 131.12M | 355.64M | 172.57M | 186.73M | 230.53M |
| Short-Term Investments | 362.50M | 354.07M | 438.97M | 462.40M | 401.92M | 434.71M | 321.66M | 337.60M | 208.35M | 150.07M | 154.89M | 90.22M |
| Total Current Assets | 807.15M | 613.46M | 577.57M | 586.42M | 602.53M | 605.86M | 591.64M | 476.77M | 570.92M | 627.55M | 355.58M | 324.88M |
| Property, Plant & Equipment | 3.46M | 3.78M | 3.86M | 4.10M | 4.11M | 3.53M | 3.19M | 2.47M | 1.78M | 1.11M | 1.20M | 1.42M |
| Long-Term Investments | 66.88M | 72.55M | 78.64M | 102.70M | 102.49M | 123.52M | 140.25M | 114.56M | 31.45M | — | — | 1.99M |
| Total Assets | 885.54M | 697.46M | 668.19M | 701.69M | 718.01M | 742.13M | 744.73M | 603.86M | 614.63M | 629.28M | 357.95M | 330.02M |
| Accounts Payable | 3.46M | 8.44M | 5.34M | 5.65M | 3.25M | 2.92M | 1.61M | 3.05M | 3.63M | 3.51M | 772.00K | 1.25M |
| Total Current Liabilities | 37.18M | 34.55M | 45.44M | 44.94M | 35.51M | 35.11M | 47.40M | 44.58M | 41.58M | 39.91M | 21.27M | 27.87M |
| Total Liabilities | 44.00M | 41.99M | 53.48M | 56.25M | 49.99M | 53.08M | 69.43M | 71.94M | 73.31M | 68.83M | 21.27M | 27.87M |
| Shareholders' Equity | 841.54M | 655.47M | 614.71M | 645.44M | 668.02M | 689.05M | 675.29M | 531.91M | 541.32M | 560.44M | 336.68M | 302.15M |
| Retained Earnings | -304.04M | -466.89M | -470.67M | -426.29M | -386.95M | -352.18M | -340.52M | -472.20M | -438.99M | -408.37M | -615.71M | -643.04M |
| Net Cash (Debt) | 782.58M | 547.79M | 567.36M | 576.12M | 570.47M | 574.36M | 418.91M | 468.72M | 564.00M | 322.63M | 341.62M | 320.75M |
| Shares Outstanding | 64.67M | 64.23M | 62.58M | 62.45M | 62.11M | 61.93M | 61.04M | 59.52M | 58.76M | 58.60M | 57.71M | 57.65M |
This table shows 12 quarterly periods of Protagonist Therapeutics's balance sheet, from Q2 2026 back to Q3 2023, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow PTGX's reporting calendar. What is a balance sheet?